ResearcherNankai UniversityNo recent work listed
Yuanjun Sun
Matched on ORCID iD 0000-0001-8035-3284; OpenAlex author ID A5014638795. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers
Papers 3
- Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2. Co-author DOI 10.1002/anie.202206953↗
- Corrigendum: Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2. Co-author DOI 10.1002/anie.202211687↗
- Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. Co-author DOI 10.1002/anie.201709744↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yue Chen · 3 shared papers, 2017–2022 · strength 0.35
- Paper Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-4… DOI 10.1002/anie.202206953↗
- Paper Corrigendum: Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer T… DOI 10.1002/anie.202211687↗
- Paper Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells. DOI 10.1002/anie.201709744↗
- Can Liu · 2 shared papers, 2022 · strength 0.29
- Paper Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-4… DOI 10.1002/anie.202206953↗
- Paper Corrigendum: Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer T… DOI 10.1002/anie.202211687↗
- Yahui Ding · 2 shared papers, 2017–2022 · strength 0.21
- Tianyang Chen · 1 shared paper, 2022 · strength 0.15
- Juan Yang · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.